Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

April 30, 2016

Conditions
Biliary Tract Cancer
Interventions
DRUG

Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine

HAI of Oxaliplatin and Fluorouracil: Oxaliplatin 130mg/m2 in split daily doses for 3 days, Fluorouracil 3000 mg/m2 in split daily doses for 3 days. Intraarterial Oxaliplatin plus intravenous Leucovorin 200 mg/m2 simultaneously over 2 hours followed by intraarterial Fluorouracil over 22 hours on Days 1-3 of each cycle, repeat every 21 days. After 4-6 cycles of HAI, maintenance treatment continue, Maintenance of Oral capecitabine 1,000 mg/m2 twice a day from days 1-14, Cycles were repeated every 21 days.

Trial Locations (1)

100142

Peking University Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT01572324 - Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas | Biotech Hunter | Biotech Hunter